|
Market Cap (17-May) $36,803,800 (436th) |
Close (30-Jun) $0.310 |
Volume (30-Jun) 965,700 |
Shortsold (5-May) 630,735 (0.15%) (400th) |
|
52w High $0.130 |
52w Low $0.086 |
P/E 312.50 |
EPS -0.03 |
SPL released this announcement to the ASX on 29 October 2021, 14:05. The announcement is not marked as price sensitive, and is 22 page(s) in length and 2.04MB in size.
You can view all announcements from SPL and see how they appear on a price chart on the announcements page.
At the date of this announcement, SPL was 2.419% short sold according to ASIC data. It was ranked the 78th most shorted stock on the ASX. It remains ranked 400th as of the latest reported data (05 May 2025).
| Other Recent Announcements from SPL | |
|---|---|
| Clinical Trial Update | 27 June 2023, 9:57 |
| Life Sciences Investor Forum Presentation | 23 June 2023, 10:42 |
| Starpharma to present at Life Sciences Investor Forum | 22 June 2023, 12:48 |
| Notice of Annual General Meeting/Proxy Form | 29 October 2021, 14:05 |
| Quarterly Cashflow and Activities Report | 29 October 2021, 9:57 |
| Starpharma to present DEP at US Drug Delivery Conference | 28 October 2021, 9:54 |
| VIRALEZE distribution and supply to Vietnam | 26 October 2021, 9:57 |
You must be logged in to post a reply.
Starpharma Holdings 